Scribe Therapeutics, Inc.

SCTX · XNAS

CIK 1853921fmd_1Y04QGHWC0KYBEWS3H5WZF8KQEManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).